Note: Check with your organization’s library for availability.
A. “Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function,” by Chia-Chen Liu, Jing Zhao, Yuan Fu, Yasuteru Inoue, Yingxue Ren, Yuanxin Chen, Sydney V. Doss, Francis Shue, Suren Jeevaratnam, Ligia Bastea, Na Wang, Yuka A. Martens, Wenhui Qiao, Minghui Wang, Na Zhao, Lin Jia, Yu Yamazaki, Akari Yamazaki, Cassandra L. Rosenberg, Zhen Wang, Dehui Kong, Zonghua Li, Lindsey A. Kuchenbecker, Zachary A. Trottier, Lindsey Felton, Justin Rogers, Zachary S. Quicksall, Cynthia Linares, Joshua Knight, Yixing Chen, Aishe Kurti, Takahisa Kanekiyo, John D. Fryer, Yan W. Asmann, Peter Storz, Xusheng Wang, Junmin Peng, Bin Zhang, Betty Y. S. Kim & Guojun Bu (Vol. 25, No. 8, August 2022, p. 1020-1033).
www.nature.com/articles/s41593-022-01127-0
B. “Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex,” by Emma Gerrits, Lucia A. A. Giannini, Nieske Brouwer, Shamiram Melhem, Danielle Seilhean, Isabelle Le Ber, The Brainbank Neuro-CEB Neuropathology Network, Alwin Kamermans, Gijs Kooij, Helga E. de Vries, Erik W. G. M. Boddeke, Harro Seelaar, John C. van Swieten & Bart J. L. Eggen (Vol. 25, No. 8, August 2022, p. 1034-1048).
www.nature.com/articles/s41593-022-01124-3